We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 10,000 results
  1. The circRNA hsa-circ-0013561 regulates head and neck squamous cell carcinoma development via the miR-7-5p/PDK3 axis

    Background

    Circular RNAs (circRNAs) belong to a class of covalently closed single stranded RNAs that have been implicated in cancer progression....

    Kaisai Tian, Liying Zheng, ... Yi Zhang in Cancer Cell International
    Article Open access 01 March 2024
  2. Non B Cell-Derived Immunoglobulins in Lung Epithelial Cells and Lung Cancer

    As the locus for air exchange, lung tissue is perpetually exposed to a significant quantity of foreign pathogens. Consequently, lung has developed a...
    **gshu Tang, Erya Gao, ... Wenwei Shao in Non B cell-Derived Immunoglobulins
    Chapter 2024
  3. Identification and validation of a novel risk model based on cuproptosis‑associated m6A for head and neck squamous cell carcinoma

    Background

    Head and neck squamous cell carcinoma (HNSCC) is a prevalent cancer with a poor survival rate due to anatomical limitations of the head and...

    Zhongxu **ng, Yijun Xu, ... Lili Wang in BMC Medical Genomics
    Article Open access 22 May 2024
  4. circ0005027 Acting as a ceRNA Affects the Malignant Biological Behavior of Hypopharyngeal Squamous Cell Carcinoma by Modulating miR-548c-3p/CDH1 Axis

    Hypopharyngeal squamous cell carcinoma (HSCC) is a malignant tumor of head and neck. It was verified that circ0005027 was downregulated in HSCC...

    ** Yang, Chun Feng, ... **aoguang He in Biochemical Genetics
    Article 29 November 2023
  5. SIRT3 Promotes the Development of Esophageal Squamous Cell Carcinoma by Regulating Hexokinase 2 through the AKT Signaling Pathway

    In the present study, we explored whether sirtuin-3 (SIRT3) regulates the proliferation and migration of esophageal squamous cell carcinoma (ESCC)...

    M. L. Yuan, L. H. Ren, ... R. H. Shi in Bulletin of Experimental Biology and Medicine
    Article 28 November 2022
  6. Analysis of Methylome of Different Forms of Basal Cell Hyperplasia and Squamous Cell Metaplasia of Bronchial Epithelium

    Squamous cell lung cancer (SCLC) occurs as a result of dysregenerative changes in the bronchial epithelium: basal cell hyperplasia (BCH), squamous...

    A. A. Ponomaroyva, A. A. Schegoleva, ... E. V. Denisov in Bulletin of Experimental Biology and Medicine
    Article 04 July 2024
  7. RUNX1/miR-429 feedback loop promotes growth, metastasis, and epithelial-mesenchymal transition in oral squamous cell carcinoma by targeting ITGB1

    This study aimed to explore the role of miR-429 on the progression of oral squamous cell carcinoma (OSCC). OSCC cell lines were transfected with...

    Xun Lu, Yiqiang Yang, ... **aofan Zhao in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 26 January 2024
  8. Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription

    Background

    Epigenetic dysregulation is essential to the tumorigenesis of oral squamous cell carcinoma (OSCC). SET and MYND domain-containing protein 3...

    Zongcheng Yang, Fen Liu, ... Zhihong Zhang in Clinical Epigenetics
    Article Open access 26 May 2023
  9. Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications

    Background

    Occurrence of squamous cell carcinoma (SCC) even in early-stage, untreated chronic lymphocytic leukemia (CLL) patients can be a significant...

    Sutapa Sinha, Ray Guo, ... Neil E. Kay in British Journal of Cancer
    Article 17 June 2024
  10. Identification of a serum-based microRNA signature that detects recurrent oral squamous cell carcinoma before it is clinically evident

    Background

    Survival rates for oral squamous cell carcinoma (OSCC) have remained poor for decades, a fact largely attributable to late-stage diagnoses...

    Rebecca Towle, Christopher T. D. Dickman, ... Cathie Garnis in British Journal of Cancer
    Article Open access 05 October 2023
  11. First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study

    Although antiprogrammed death 1 antibody plus chemotherapy has recently been approved for first-line esophageal squamous cell carcinoma (ESCC),...

    ** Li, Zhendong Chen, ... Jason Yang in Nature Medicine
    Article 01 February 2024
  12. The prognostic role of coagulation markers in the progression and metastasis of laryngeal squamous cell carcinoma

    Background

    The application of coagulation-related markers in laryngeal squamous cell carcinoma(LSCC) remains unclear. This study explored the...

    Qiongling Huang, **g Chen, ... Chaohui Zheng in BMC Cancer
    Article Open access 25 September 2023
  13. Stemness-related lncRNAs signature as a biologic prognostic model for head and neck squamous cell carcinoma

    Cancer stem cells (CSCs) and long non-coding RNAs (lncRNAs) are particularly important for tumor cell growth and migration, and recurrence and drug...

    Zejun Xu, Min Zhang, ... Jian Liu in Apoptosis
    Article 30 March 2023
  14. RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway

    Background

    Novel therapeutic targets are urgently needed for treating drug-resistant non-small cell lung cancer (NSCLC) and overcoming drug resistance...

    **aoyan Ding, **aoxia Li, ... Robert Chunhua Zhao in Cancer Cell International
    Article Open access 02 March 2024
  15. AIM2 promotes irradiation resistance, migration ability and PD-L1 expression through STAT1/NF-κB activation in oral squamous cell carcinoma

    Background

    Radioresistance and lymph node metastasis are common phenotypes of refractory oral squamous cell carcinoma (OSCC). As a result,...

    Hui-Wen Chiu, Hsin-Lun Lee, ... Che-Hsuan Lin in Journal of Translational Medicine
    Article Open access 03 January 2024
  16. CT-based delta-radiomics nomogram to predict pathological complete response after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma patients

    Background

    This study developed a nomogram model using CT-based delta-radiomics features and clinical factors to predict pathological complete...

    Liyuan Fan, Zhe Yang, ... Qiang Wen in Journal of Translational Medicine
    Article Open access 18 June 2024
  17. The predicting role of serum tumor-specific growth factor for prognosis of esophageal squamous cell carcinoma

    Objective

    Tumor-specific growth factor (TSGF) is an immune-related factor that offers good performance in the clinical management of human cancers....

    **aoqin Xu, Weigang Wang, ... Jiexian **g in BMC Cancer
    Article Open access 06 November 2023
  18. Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial

    Anti-programmed cell death protein 1 (PD-1) therapy is a standard of care in recurrent metastatic head and neck squamous cell carcinoma (RMHNSCC)....

    Nabil F. Saba, Conor E. Steuer, ... Christine H. Chung in Nature Medicine
    Article 03 April 2023
  19. STK3 kinase activation inhibits tumor proliferation through FOXO1-TP53INP1/P21 pathway in esophageal squamous cell carcinoma

    Purpose

    Esophageal squamous cell carcinoma (ESCC) is an aggressive disease with a poor prognosis, caused by the inactivation of critical cell growth...

    Ziying Zhao, Yuan Chu, ... Meidong Xu in Cellular Oncology
    Article Open access 04 March 2024
  20. Clinical and prognostic significance of perioperative change in red cell distribution width in patients with esophageal squamous cell carcinoma

    Background

    Numerous studies have reported the prognostic significance of the red cell distribution width (RDW) in patients with esophageal squamous...

    Peng Zhang, Sheng Wang, ... Qian Song in BMC Cancer
    Article Open access 06 April 2023
Did you find what you were looking for? Share feedback.